Details

Autor(en) / Beteiligte

• Fox, James A., MD, FAAAAI
• Martinez-Saguer, Inmaculada
• Vegh, Arthur B., MD, FAAAAI
• Wuillemin, Walter A., PhD, MD
• Edelman, Jonathan M., MD
• Williams-Herman, Debora, MD
• Rojavin, Mikhail, PhD
• Rosenberg, Tanja, MD

Titel

Safety of a C1 Esterase Inhibitor Concentrate in Pregnant Women with Hereditary Angioedema: Findings from the International Berinert Patient Registry

Ist Teil von

• Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB243-AB243

Ort / Verlag

St. Louis: Elsevier Inc

Erscheinungsjahr

2016

Quelle

Elsevier ScienceDirect Journals

Beschreibungen/Notizen

• Of the remaining three pregnancies: one (16-year-old subject) was voluntarily terminated at 9 weeks gestation; a second (30-year-old subject, previous miscarriage) ended as a first-trimester spontaneous abortion one week after the subject's last pnf-C1INH infusion and was considered unrelated to pnf-C1INH treatment; the third occurred in a 30-year-old subject who exited the registry approximately two months before her due date with no further follow-up, although no AEs or complications were recorded up to that point.